Prevalence of Psychiatric Disorders During Pregnancy at 2nd Trimester Ultrasound: a Feasibility Study in the General Population - Trial NCT06297252
Access comprehensive clinical trial information for NCT06297252 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Montpellier and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 140 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospital, Montpellier
Timeline & Enrollment
N/A
Apr 25, 2024
Oct 24, 2026
Primary Outcome
To determine the prevalence of the presence of at least one characterized psychiatric disorder, in remission or not, during pregnancy, at the time of the second-trimester ultrasound (T2 ultrasound) based on a standardized clinical assessment.
Summary
Young women represent a population at risk of psychiatric disorders, the first signs of which
 often appear between the ages of 15 and 25. Psychiatric disorders are a major source of
 disability and healthcare costs.
 
 The perinatal period is an additional period of psychological vulnerability, during which
 women are at increased risk of developing or worsening psychiatric disorders. Unfortunately,
 psychiatric disorders seem to be largely under-diagnosed during this period, and therefore
 under-treated.
 
 The goal of this Prospective multicenter study is to determine the prevalence of the presence
 of at least one characterized psychiatric disorder, as defined by the use of the Mini
 International Neuropsychiatric Interview (MINI), in remission or not, during pregnancy, at
 the time of the second-trimester ultrasound (T2 ultrasound) based on a standardized clinical
 assessment.
 
 Participants will complete self-questionnaires and have a standardized psychiatric evaluation
 at T2 ultrasound and at 2 months postpartum.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06297252
Non-Device Trial

